These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1349 related items for PubMed ID: 18049330

  • 21. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 22. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.
    Hayashi T, Nakao K, Nagayama Y, Saitoh O, Ichikawa T, Ishikawa H, Hamasaki K, Eguchi K, Ishii N.
    Int J Oncol; 2005 May; 26(5):1313-9. PubMed ID: 15809723
    [Abstract] [Full Text] [Related]

  • 23. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model.
    Pilon-Thomas S, Li W, Briggs JJ, Djeu J, Mulé JJ, Riker AI.
    J Immunother; 2006 May; 29(4):381-7. PubMed ID: 16799333
    [Abstract] [Full Text] [Related]

  • 24. Antitumor immunity by a dendritic cell vaccine encoding secondary lymphoid chemokine and tumor lysate on murine prostate cancer.
    Lu J, Zhang Q, Liang CM, Xia SJ, Zhong CP, Wang DW.
    Asian J Androl; 2008 Nov; 10(6):883-9. PubMed ID: 18958352
    [Abstract] [Full Text] [Related]

  • 25. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y, Saxena A, Zheng C, Carlsen S, Xiang J.
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [Abstract] [Full Text] [Related]

  • 26. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 27. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
    Mochimaru H, Nagai N, Hasegawa G, Kudo-Saito C, Yaguchi T, Usui Y, Kurihara T, Koto T, Satofuka S, Shinoda H, Ozawa Y, Tsubota K, Kawakami Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Oct 15; 48(10):4795-801. PubMed ID: 17898306
    [Abstract] [Full Text] [Related]

  • 28. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
    Jérôme V, Graser A, Müller R, Kontermann RE, Konur A.
    J Immunother; 2006 Oct 15; 29(3):294-305. PubMed ID: 16699372
    [Abstract] [Full Text] [Related]

  • 29. Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy.
    Heckelsmiller K, Beck S, Rall K, Sipos B, Schlamp A, Tuma E, Rothenfusser S, Endres S, Hartmann G.
    Eur J Immunol; 2002 Nov 15; 32(11):3235-45. PubMed ID: 12555669
    [Abstract] [Full Text] [Related]

  • 30. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J, Wang CL, Hao XS.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2785-90. PubMed ID: 18167273
    [Abstract] [Full Text] [Related]

  • 31. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y.
    Clin Cancer Res; 2009 Jul 15; 15(14):4612-21. PubMed ID: 19584156
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of anti-tumor effects of tumor cell lysate enriched by HSP-70 against fibrosarcoma tumor in BALB/c mice.
    Hashemi SM, Hassan ZM, Soudi S, Ghazanfari T, Kheirandish M, Shahabi S.
    Int Immunopharmacol; 2007 Jul 15; 7(7):920-7. PubMed ID: 17499194
    [Abstract] [Full Text] [Related]

  • 33. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
    Jack AM, Aydin N, Montenegro G, Alam K, Wallack M.
    J Surg Res; 2007 May 15; 139(2):164-9. PubMed ID: 17275030
    [Abstract] [Full Text] [Related]

  • 34. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD, Chihara H, Kobayashi G, Zhu X, Miller MA, Scott DL, Krieg AM.
    Cancer Res; 2003 Jan 15; 63(2):394-9. PubMed ID: 12543793
    [Abstract] [Full Text] [Related]

  • 35. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
    Yamaguchi S, Tatsumi T, Takehara T, Sakamori R, Uemura A, Mizushima T, Ohkawa K, Storkus WJ, Hayashi N.
    Cancer; 2007 Oct 01; 110(7):1469-77. PubMed ID: 17685394
    [Abstract] [Full Text] [Related]

  • 36. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
    Viehl CT, Moore TT, Liyanage UK, Frey DM, Ehlers JP, Eberlein TJ, Goedegebuure PS, Linehan DC.
    Ann Surg Oncol; 2006 Sep 01; 13(9):1252-8. PubMed ID: 16952047
    [Abstract] [Full Text] [Related]

  • 37. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
    Driessens G, Hoffmann P, Pouwels M, Zlotta A, Schulman C, Velu T, Bruyns CA.
    J Immunother; 2009 Sep 01; 32(2):140-4. PubMed ID: 19238012
    [Abstract] [Full Text] [Related]

  • 38. CD8+ T-cell tolerance can be broken by an adenoviral vaccine while CD4+ T-cell tolerance is broken by additional co-administration of a Toll-like receptor ligand.
    Salucci V, Mennuni C, Calvaruso F, Cerino R, Neuner P, Ciliberto G, La Monica N, Scarselli E.
    Scand J Immunol; 2006 Jan 01; 63(1):35-41. PubMed ID: 16398699
    [Abstract] [Full Text] [Related]

  • 39. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E, Homann HE, Qin Z, Ju DW, Cao X.
    Gene Ther; 2002 Jun 01; 9(12):793-803. PubMed ID: 12040461
    [Abstract] [Full Text] [Related]

  • 40. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
    Davila E, Kennedy R, Celis E.
    Cancer Res; 2003 Jun 15; 63(12):3281-8. PubMed ID: 12810660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 68.